Skip to main content

$0.410 -0.010 (-2.38%)

High

$0.42

Low

$0.41

Trades

28

Turnover

$52,803

Volume

126,180
30 June 2023 at 3:42pm
Register to track RHY and receive email alerts.
Subject
RHY Ann: Rhythm Establishes US Entity To Drive US Expansion Strategy

RHY Ann: Rhythm to Present at MST Access Investor Conference

RHY Ann: RHY adds Sonic Clinical Services to ColoSTAT Clinical Trial

RHY Ann: FY22 Strategic Update

RHY Ann: Rhythm Betters ColoSTAT Results

RHY Ann: Appendix 4C - quarterly

RHY Ann: Appendix 2A and Cleansing Notice

RHY Ann: Rhythm Extends ColoSTAT Clinical Trial to Western Australia

RHY Ann: Rhythm Retains ISO13485 Certification

RHY Ann: Study 6 Successfully Concluded - Exceptional Results

RHY Ann: Appendix 4D and Half Yearly Report and Accounts

RHY Ann: Rhythm Expands ColoSTAT Clinical Trial To Tenth Site

RHY Ann: Appendix 2A and Cleansing Notice

RHY Ann: Rhythm Top 20 Shareholder Update

RHY Ann: Appendix 4C - quarterly

RHY Ann: Initial Manufacturing of ColoSTAT Test-Kits Complete

RHY Ann: Rhythm Advances ColoSTAT Study 7

RHY Ann: Change in substantial holding

RHY Ann: Response to ASX Price Query

RHY Ann: Investor Presentation - December 2020

RHY Ann: Rhythm Secures US Patent - Strengthens Global Footprint

RHY Ann: Rhythm Appoints Global Manufacturer for ColoSTAT

RHY Ann: Appendix 3G

RHY Ann: Change of Director's Interest Notice

RHY Ann: Investor Presentation

RHY Ann: Amended Constitution

RHY Ann: Results of Meeting

RHY Ann: AGM Presentation - November 2020

RHY Ann: ColoSTAT Prototype Complete, Outperforms FIT

RHY Ann: Appendix 4C - quarterly

RHY Ann: Ethics Approval Received, New Clinical Trial Site Added

RHY Ann: Rhythm Receives $1.1m R&D Tax Incentive

Register to track RHY and receive email alerts.

Similar Companies

AHX
BD1
CAJ
HLA
HLS
IDX
SHL
SLA
TTB